The robust scientific program offered at Miami Valves provides the highest quality education and networking opportunities for all specialists currently using transcatheter therapies to treat valvular and structural heart disease, as well as those looking to expand into this practice area. 

Founded by faculty of University of Miami’s centers of excellence and complemented by key opinion leaders from around the world, Miami Valves features powerhouse lectures and case presentations taught by the very best minds in the field.

EDUCATIONAL OBJECTIVES

By the conclusion of this activity, participants should be able to:

• Appraise new and upcoming technologies in the management of structural heart disease, including, valvular heart disease, stroke prevention, hemodynamic support, cardiomyopathy and high risk-percutaneous coronary intervention to determine their benefit for patients
• Evaluate the relative advantages and disadvantages of different strategies in complex cases involving valvulardisease
• Present indications, techniques, outcomes, and complications for transcathetervalve intervention in patients with native valvelesions
• Compare FDA approved technologies for TAVR and the scientific data supporting theiruse
• Examine best practice techniques for high certainty valveimplantation
• Analyze data and techniques for treatment of bioprosthetic valvedysfunction
• Evaluate the rationale, challenges, and necessity of the heart team approach to valvular heart disease, and the functionality of the team within a center ofexcellence
• Evoke the changing landscape of percutaneous and surgical techniques of valve repair and replacement
• Evaluate the barriers to care in patients with valvular heart disease with specific attention to current gaps in the timely delivery of percutaneous and surgicalinterventions
• Recognize the different diagnostic tools and combinations required to accurately diagnose specific structural heart diseases and plan transcathetertherapy
• Discuss rationale and technique of alternative access approach for aorticstenosis
• Discuss investigational valves in the near horizon including their therapeutic advantages and limitations
• Describe the advantages and pitfalls of comprehensive diagnostic techniques for patients with valvular heart disease such as cardiac computed tomography, three-dimensional echocardiography, and complex invasive hemodynamiccatheterization
• Discuss transcatheter treatment options for mitral valvedisease
• Explain the clinical data supporting mitral valve leaflet clip approximation for the treatment of mitralregurgitation
• Demonstrate and present best practice techniques for mitral valve clipapproximation
• Examine alternative investigational devices for the transcatheter treatment of mitral regurgitation
• Present alternatives with transcatheter aortic and pulmonic valve technologies for the treatment of mitraldisease
• Present progress in transcatheter mitral valvereplacement
• Present the techniques and efficacy of transcatheter treatment of mitral prosthetic valve paravalvularleaks
• Demonstrate how septal ablation and technologies can improve mitral regurgitation in hypertrophic cardiology.
• Discuss transcatheter treatment options for tricuspid valvediseaseExamine the evidence regarding closure of percutaneous closure of patent foramen ovale for stroke prevention.
• Examine the evidence regarding left atrial appendage exclusion for stroke prevention in patients with atrialfibrillation.
• Examinethedataandtechniquesforidentificationandassessmentofhemodynamically significant coronary arterylesions.
• Examine the data and techniques for coronary imaging and lesioncharacterization.Examine the data and techniques regarding new stent and bio-absorbable scaffolds for percutaneous coronary intervention, as well as devices for coronary intervention facilitation (plaque modification, chronic total occlusion).
• Examine the data and techniques for the treatment of in-stent re-stenosis, with emphasizes in new technology.
• Discuss therapeutic alternatives in patients with atrial fibrillation and the data to supportit.
• Identify the indication, techniques and complications for left atrial appendage occlusion in patients with afib.
• Recognize the risks and benefits of anticoagulation in patients with atrial fibrillation and other co-morbidities.
• Identify the role for catheter ablation for patients with atrial fibrillation based on the most recent trial
• Recognize the pathophysiology of atrial fibrillation and potential for new therapeutic targets.
• Learn and evaluate patients for advanced heart failure therapies.
• Focused learning related to multi organ transplant and special heart transplant patient population.
• Evaluation and basic management of patient with mechanical circulatory support devices including LVADs and Total artificial heart.
• Case based scenarios discussing complex advanced heart failure patients.

TARGETED AUDIENCE

This course is directed to physicians specializing in interventional and invasive cardiologists, general cardiologists, cardiovascular surgeons, vascular surgeons, and interventional radiologists.

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Vein & Lymphatic Society (AVSL) and Behind the Scenes, a Medical Education Company, LLC (BTS) . The AVLS is accredited with commendation by the ACCME to provide continuing medical education for physicians.

American Vein and Lymphatic Society designates this live activity for a maximum of 18.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.